| Methods of manufacturing treprostinil and treprostinil derivative prodrugs |
2023-4-18 |
2023-8-10 |
|
| Certain n-(1-cyano-2-phenylethyl)-1,4-oxazepane-2-carboxamides for treating … |
2023-2-16 |
2023-8-24 |
|
| Dry powder compositions of bedaquiline and salts and methods of use thereof |
2023-2-06 |
2023-8-10 |
|
| Methods for continuous manufacture of liposomal drug products |
2022-12-30 |
2023-7-13 |
|
| Lipid-based compositions of antiinfectives for treating pulmonary infections … |
2022-12-22 |
2023-5-04 |
|
| Certain n-(1-cyano-2-phenylethyl)-1,4-oxazepane-2-carboxamides for treating … |
2022-10-28 |
2023-5-04 |
|
| Methods for treating pulmonary non-tuberculous mycobacterial infections |
2022-10-07 |
2023-2-09 |
|
| Sustained release of antiinfectives |
2022-9-09 |
2023-1-12 |
|
| Dry powder compositions of treprostinil prodrugs and methods of use thereof |
2022-8-23 |
2022-12-29 |
|
| Tunable polymeric nanoparticles for targeted and sustained delivery of … |
2022-8-19 |
2023-2-23 |
|
| Adeno-associated virus particles and methods of use thereof |
2022-8-05 |
2023-2-09 |
|
| In vitro release assay methods for liposomal aminoglycoside formulations |
2022-6-08 |
2022-12-15 |
|
| Certain n-(1-cyano-2-phenylethyl)-1,4-oxazepane-2-carboxamides for treating … |
2022-4-29 |
2022-11-03 |
|
| Certain n-(1-cyano-2-phenylethyl)-1,4-oxazepane-2-carboxamides for treating … |
2022-4-28 |
2022-11-03 |
|
| Combination therapy for treating non-tuberculous mycobacterial lung disease |
2022-3-24 |
2022-9-29 |
|
| Dry powder compositions of glycopeptide derivative compounds and methods of use … |
2022-3-18 |
2022-9-22 |
|
| Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for … |
2022-1-14 |
2022-5-05 |
|
| Certain (25)-iv-[(ls')~ i-c yan0-2-phenylethyl·]- 1,4-oxazepane-2- carboxamides … |
2021-12-22 |
2022-6-30 |
|
| Dry powder compositions of treprostinil prodrugs and methods of use thereof |
2021-10-28 |
2022-5-05 |
|
| Methods for treating newly diagnosed mycobacterium avium complex lung … |
2021-8-30 |
2023-3-02 |
|
| Methods for extracting neutrophil serine proteases and treating dipeptidyl … |
2021-7-19 |
2023-5-24 |
|
| Lipo-glycopeptide cleavable derivatives and uses thereof |
2021-6-10 |
2022-5-05 |
|
| Pharmaceutical formulations of treprostinil prodrugs and methods of use thereof |
2021-3-25 |
2023-2-08 |
|
| Deimmunized lysostaphin and methods of use |
2021-3-12 |
2021-12-23 |
|
| Sustained release of antiinfectives |
2021-3-10 |
2022-1-20 |
|
| Prostacyclin compounds |
2021-3-02 |
2021-4-30 |
|
| Systems for treating pulmonary infections |
2021-2-12 |
2021-12-02 |
|
| Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for … |
2021-1-25 |
2021-6-24 |
|
| Sustained release of antiinfectives |
2020-10-30 |
2021-4-29 |
|
| Methods for treating pulmonary non-tuberculous mycobacterial infections |
2020-9-22 |
2020-12-11 |
|
| Compositions and methods for treating lung diseases and lung injury |
2020-5-22 |
2020-6-11 |
|
| Lipo-glycopeptide cleavable derivatives and uses thereof |
2019-11-20 |
2021-9-29 |
|
| Glycopeptide derivative compounds and uses thereof |
2019-11-20 |
2021-9-29 |
|
| Specific (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepan-2-carboxamide for … |
2019-7-16 |
2021-3-24 |
|
| Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for … |
2019-7-16 |
2020-1-23 |
|
| Methods for the manufacture of liposomal drug formulations |
2019-5-02 |
2019-11-07 |
|
| Stabilized vancomycin formulations |
2018-9-26 |
2019-11-12 |
2019-11-12 |
| Compositions of multicationic drugs for reducing interactions with polyanionic … |
2018-2-12 |
2018-6-21 |
|
| Methods of treating pulmonary disorders with liposomal amikacin formulations |
2017-6-30 |
2017-12-21 |
|
| Prostacyclin compounds and compositions for treating sarcoidosis |
2017-6-23 |
2017-12-28 |
|
| Antibodies and methods of making same |
2017-5-24 |
2023-5-16 |
2023-5-16 |
| Methods of treating pulmonary disorders with liposomal amikacin formulations |
2017-4-27 |
2017-6-29 |
|
| Compositions and methods for treating bacterial infections |
2016-11-18 |
2017-6-15 |
|
| High delivery rates for lipid based drug formulations, and methods of treatment … |
2016-9-27 |
2017-1-19 |
|
| Compositions comprising copper chelators and methods of use thereof for … |
2016-7-28 |
2017-2-02 |
|
| Compositions and methods for the treatment of sarcoidosis |
2016-7-25 |
2017-2-02 |
|
| Prostacyclin compounds, compositions and methods of use thereof |
2016-4-29 |
2016-11-03 |
|
| Prostacylin compositions and methods for using the same |
2016-4-07 |
2016-10-07 |
|
| Platinum aggregates and process for producing the same |
2015-10-12 |
2016-9-15 |
|
| Methods of treating cancer with high potency lipid-based platinum compound … |
2015-7-10 |
2016-6-16 |
|
| LONG-TERM RELEASE OF ANTI-COLLAPSE MEDICINES |
2015-6-17 |
2017-2-08 |
|
| Prostacylin compositions and methods for using the same |
2015-3-10 |
2015-9-17 |
|
| Prostacyclin compounds, compositions and methods of use thereof |
2014-10-24 |
2021-6-29 |
|
| Prostacyclin compounds, compositions and methods of use thereof |
2014-10-24 |
2021-3-26 |
|
| Prostacyclin compounds, compositions and methods of use thereof |
2014-10-24 |
2021-6-29 |
|
| Prostacyclin compounds, compositions and methods of use thereof |
2014-10-24 |
2016-5-12 |
|
| Low resistance aerosol exhalation filter |
2014-7-17 |
2018-11-08 |
2018-11-08 |
| Liposomal vancomycin formulations |
2014-5-20 |
2016-11-24 |
2016-11-24 |
| Methods of treating pulmonary disorders with liposomal amikacin formulations |
2014-3-25 |
2014-4-17 |
|
| Method for treating pulmonary disorders with liposomal amikacin formulations |
2012-8-03 |
2016-5-10 |
2016-5-10 |
| Methods for coacervation induced liposomal encapsulation and formulations … |
2007-4-04 |
2018-2-21 |
2018-2-21 |
| Purified rhIGF-I/rhIGFBP-3 complexes and their method of manufacture |
2005-12-20 |
2011-6-28 |
2011-6-28 |
| Lipoxygenase inhibitors as hypolipidemic and anti-hypertensive agents |
2003-12-18 |
2004-7-22 |
|
| Methods for the production of D-chiro-inositol and the use of D-chiro-inositol … |
2002-11-08 |
2005-8-26 |
|
| Compositions and methods for preventing neural tube disorders |
2002-6-05 |
2002-12-12 |
|
| Compositions comprising D-chiro inositol and lipid lowering compounds |
2002-5-17 |
2006-2-11 |
2006-2-11 |
| Compositions comprising d-chiro inositol and lipid lowering compounds and … |
2002-5-15 |
2002-12-03 |
|
| Compositions comprising d-chiro inositol and sulfonylureas and methods of … |
2002-5-01 |
2003-4-24 |
|
| Compositions containing hypotriglyceridemically active stilbenoids |
2001-8-16 |
2002-2-21 |
|
| Compositions containing hypotriglyceridemically active stilbenoids |
2001-8-15 |
2003-5-21 |
|
| Compositions containing hypoglycemically active stilbenoids |
2001-8-15 |
2005-4-27 |
2005-4-27 |
| Compositions containing hypoglycemically active stilbenoids |
2001-8-15 |
2002-9-12 |
|